U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry UNKNOWN
Molecular Formula C7H15N
Molecular Weight 113.2007
Optical Activity UNSPECIFIED
Defined Stereocenters 0 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of NANOFIN

SMILES

CC1CCCC(C)N1

InChI

InChIKey=SDGKUVSVPIIUCF-UHFFFAOYSA-N
InChI=1S/C7H15N/c1-6-4-3-5-7(2)8-6/h6-8H,3-5H2,1-2H3

HIDE SMILES / InChI

Description

Nanofin is a ganglion blocker alkaloid having nicotinic acetylcholine receptor antagonist action. It has an antihypertensive effect used for mild to moderate hypertension. It was also used for the treatment of eczema and neurodermatitis.

Approval Year

Unknown
139594
Targets

Targets

Primary TargetPharmacologyConditionPotency
Nicotinic acetylcholine receptor
10
Target ID: Nicotinic acetylcholine receptor
Antagonist
2778
PubMed

PubMed

TitleDatePubMed
Mechanism of hydrodenitrogenation on phosphides and sulfides.
2005 Feb 17
Patents

Patents

04377576
1
04614806
1
04684652
1
05985253
1
07196104
2
07645773
1
Name Type Language
NANOFIN
INN  
INN  
Official Name English
nanofin [INN]
Common Name English
NSC-63890
Code English
2,6-LUPETIDINE
Systematic Name English
Classification Tree Code System Code
NCI_THESAURUS C66886
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
Code System Code Type Description
NCI_THESAURUS
C76789
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
INN
1085
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
PUBCHEM
68843
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
NSC
63890
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
SMS_ID
100000084465
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
EPA CompTox
DTXSID8048527
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
EVMPD
SUB09149MIG
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
FDA UNII
329I5805BP
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
MESH
C008581
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
ChEMBL
CHEMBL2104431
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
WIKIPEDIA
2,6-Dimethylpiperidine
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
CAS
504-03-0
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
ECHA (EC/EINECS)
207-981-6
Created by admin on Fri Dec 15 16:30:14 GMT 2023 , Edited by admin on Fri Dec 15 16:30:14 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of NANOFIN
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966